Rothwell, PM; Price, JF; Fowkes, FGR; Zanchetti, A; Roncaglioni, MC; Tognoni, G; Lee, R; Belch, JFF; Wilson, M; Mehta, Z; +1 more... Meade, TW; (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet, 379 (9826). pp. 1602-1612. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(11)61720-0 Full text not available from this repository.

Rothwell, PM; Wilson, M; Price, JF; Belch, JFF; Meade, TW; Mehta, Z; (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet, 379 (9826). pp. 1591-1601. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(12)60209-8 Full text not available from this repository.

Ioannidis, JPA; Evans, SJW; Gotzsche, PC; O'Neill, RT; Altman, DG; Schulz, K; Moher, D; (2004) Better reporting of harms in randomized trials: An extension of the CONSORT statement. Annals of internal medicine, 141 (10). pp. 781-8. ISSN 0003-4819 https://researchonline.lshtm.ac.uk/id/eprint/14000 Full text not available from this repository.

Altman, DG; Schulz, KF; Moher, D; Egger, M; Davidoff, F; Elbourne, D; Gotzsche, PC; Lang, T; (2001) The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/17239 Full text not available from this repository.